These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 14535841

  • 1. Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variant.
    Vrablík M, Horínek A, Ceska R, Stulc T, Kvasnicka T.
    Physiol Res; 2003; 52(5):647-50. PubMed ID: 14535841
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
    März W, Hoffmann MM, Scharnagl H, Fisher E, Chen M, Nauck M, Feussner G, Wieland H.
    J Lipid Res; 1998 Mar; 39(3):658-69. PubMed ID: 9548597
    [Abstract] [Full Text] [Related]

  • 3. Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.
    Smit M, de Knijff P, van der Kooij-Meijs E, Groenendijk C, van den Maagdenberg AM, Gevers Leuven JA, Stalenhoef AF, Stuyt PM, Frants RR, Havekes LM.
    J Lipid Res; 1990 Jan; 31(1):45-53. PubMed ID: 2313204
    [Abstract] [Full Text] [Related]

  • 4. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P, van den Maagdenberg AM, Boomsma DI, Stalenhoef AF, Smelt AH, Kastelein JJ, Marais AD, Frants RR, Havekes LM.
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [Abstract] [Full Text] [Related]

  • 5. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
    Mulder M, van der Boom H, de Knijff P, Braam C, van den Maagdenberg A, Leuven JA, Havekes LM.
    Atherosclerosis; 1994 Aug; 108(2):183-92. PubMed ID: 7980718
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
    Smelt AH, de Beer F.
    Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
    Wardell MR, Rall SC, Brennan SO, Nye ER, George PM, Janus ED, Weisgraber KH.
    J Lipid Res; 1990 Mar; 31(3):535-43. PubMed ID: 2341812
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A, Wassef H, Tremblay M, Bernier L, Dufour R, Davignon J.
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
    Horie Y, Fazio S, Westerlund JR, Weisgraber KH, Rall SC.
    J Biol Chem; 1992 Jan 25; 267(3):1962-8. PubMed ID: 1730728
    [Abstract] [Full Text] [Related]

  • 15. Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136-->Ser) variant in multigenerational pedigree studies.
    Pocovi M, Cenarro A, Civeira F, Myers RH, Casao E, Esteban M, Ordovas JM.
    Atherosclerosis; 1996 Apr 26; 122(1):33-46. PubMed ID: 8724110
    [Abstract] [Full Text] [Related]

  • 16. Three-dimensional structure of the LDL receptor-binding domain of the human apolipoprotein E2 (Arg136-->Cys) variant.
    Feussner G, Albanese M, Valencia A.
    Atherosclerosis; 1996 Oct 25; 126(2):177-84. PubMed ID: 8902143
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE, Ghiselli G, Brewer HB.
    J Clin Endocrinol Metab; 1983 Nov 25; 57(5):969-74. PubMed ID: 6578216
    [Abstract] [Full Text] [Related]

  • 19. Familial dysbetalipoproteinemic subjects with the E3/E2 phenotype exhibit an E2 isoform with only one cysteine residue.
    Smit M, de Knijff P, Frants RR, Klasen EC, Havekes LM.
    Clin Genet; 1987 Nov 25; 32(5):335-41. PubMed ID: 3690877
    [Abstract] [Full Text] [Related]

  • 20. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G, Dobmeyer J, Nissen H, Hansen TS.
    Am J Med Genet; 1996 Oct 16; 65(2):149-54. PubMed ID: 8911609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.